Compounds > phenylbutazone

phenylbutazone and n-formylmethionine

phenylbutazone has been researched along with n-formylmethionine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chenoweth, DE; Fiegel, VD; Gracyk, JM; Herron, MJ; Nelson, RD1
Hakim, J; Labro, MT; Perianin, A1
Dahinden, C; Fehr, J1

Other Studies

3 other study(ies) available for phenylbutazone and n-formylmethionine

ArticleYear
Chemotactic deactivation of human neutrophils: protective influence of phenylbutazone.
    Blood, 1981, Volume: 58, Issue:4

    Topics: Anaphylatoxins; Cell Movement; Chemotaxis, Leukocyte; Complement C5; Complement C5a; Dipeptides; Humans; N-Formylmethionine; Neutrophils; Phenylbutazone; Receptors, Cell Surface; Receptors, Complement; Receptors, Formyl Peptide

1981
Chemokinetic activity of N-formyl-methionyl-leucyl-phenylalanine on human neutrophils, and its modulation by phenylbutazone.
    Biochemical pharmacology, 1982, Oct-01, Volume: 31, Issue:19

    Topics: Chemotaxis, Leukocyte; Humans; Kinetics; Klebsiella pneumoniae; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Zymosan

1982
Receptor-directed inhibition of chemotactic factor-induced neutrophil hyperactivity by pyrazolon derivatives. Definition of a chemotactic peptide antagonist.
    The Journal of clinical investigation, 1980, Volume: 66, Issue:5

    Topics: Agranulocytosis; Arachidonic Acids; Aspirin; Cell Adhesion; Chemotactic Factors; Chemotaxis, Leukocyte; Dose-Response Relationship, Drug; Humans; Indomethacin; Methionine; N-Formylmethionine; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Phenylbutazone; Sulfinpyrazone

1980